← Evidence map

ArticleBritish journal of haematology2014

Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma?

Daniel J Landsburg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Could treatment with R-HCVAD/R-MA as compared to R-CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? | OpenQuestion